LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 12.28 | 770.25 | 1252 | 1358 | 0.9219 | 0.8107 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 12.28 | 770.25 | 1311 | 1358 | 0.9653 | 0.9155 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 14.50 | 770.25 | 1272 | 1497 | 0.8496 | 0.6873 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 14.50 | 770.25 | 1356 | 1497 | 0.9057 | 0.8037 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 16.73 | 770.25 | 1294 | 1664 | 0.7774 | 0.5947 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 16.73 | 770.25 | 1398 | 1664 | 0.8399 | 0.7095 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 18.95 | 770.25 | 1366 | 1832 | 0.7454 | 0.5812 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 18.95 | 770.25 | 1417 | 1832 | 0.7733 | 0.6283 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 21.17 | 770.25 | 1433 | 2008 | 0.7135 | 0.5668 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 21.17 | 770.25 | 1458 | 2008 | 0.7260 | 0.5865 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 23.39 | 770.25 | 1571 | 2244 | 0.6999 | 0.5871 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 23.39 | 770.25 | 1577 | 2244 | 0.7026 | 0.5911 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 25.62 | 770.25 | 1726 | 2514 | 0.6863 | 0.6042 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 25.62 | 770.25 | 1715 | 2514 | 0.6819 | 0.5982 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 27.84 | 770.25 | 1891 | 2833 | 0.6673 | 0.6127 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 27.84 | 770.25 | 1869 | 2833 | 0.6595 | 0.6027 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 30.06 | 770.25 | 1996 | 3106 | 0.6426 | 0.6053 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 30.06 | 770.25 | 2052 | 3106 | 0.6606 | 0.6276 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 32.28 | 770.25 | 2094 | 3392 | 0.6172 | 0.5961 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 32.28 | 770.25 | 2159 | 3392 | 0.6363 | 0.6190 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 34.50 | 770.25 | 2265 | 3712 | 0.6102 | 0.6087 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 34.50 | 770.25 | 2294 | 3712 | 0.6180 | 0.6177 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 36.73 | 770.25 | 2428 | 4086 | 0.5942 | 0.6111 | MN20160304_L02 | C17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 36.73 | 770.25 | 2423 | 4086 | 0.5930 | 0.6097 | MN20160304_L02 | K10 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 38.95 | 770.25 | 2653 | 4543 | 0.5839 | 0.6209 | MN20160304_L02 | C17 |